e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SAB Biotherapeutics, Inc. - Common Stock
(NQ:
SABS
)
2.340
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SAB Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
October 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 19, 2025
Via
Benzinga
Why Is SAB BIO Stock Trading Lower On Tuesday?
January 28, 2025
SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 19, 2025
Via
Benzinga
Top movers in Friday's session
September 19, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Which stocks are gapping on Friday?
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
SAB BIO Highlights Data in Multiple Presentations at EASD
September 19, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
September 03, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Which stocks are moving before the opening bell on Wednesday?
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 03, 2025
Via
Benzinga
SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
August 07, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 21, 2025
Via
Benzinga
SAB BIO Announces Oversubscribed $175 Million Private Placement
July 21, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 21, 2025
Via
Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
January 28, 2025
Via
Benzinga
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
May 09, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
January 28, 2025
Via
Benzinga
SAB BIO Reports Full Year 2024 Operating and Financial Results
March 31, 2025
SAB-142 Phase 1 trial positive topline data announced at KOL event
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
January 28, 2025
Via
Benzinga
Topics
Stocks
SAB BIO to Participate in Upcoming Investor Conferences
January 31, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update
November 06, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
January 28, 2025
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
October 31, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy
January 23, 2025
Investor webinar scheduled Tuesday, January 28, 2025, at 8:00 AM EST
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via
Benzinga
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
September 13, 2024
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube